Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Editorial

  • 234 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 23
  • 24
  • Next →
Let’s talk about Reviewer Rewards
Sarah Jackson
Sarah Jackson
Published January 2, 2019
Citation Information: J Clin Invest. 2019. https://doi.org/10.1172/JCI126935.
View: Text | PDF

Let’s talk about Reviewer Rewards

  • Text
  • PDF
Abstract

The JCI and JCI Insight announce the Reviewer Rewards program to recognize the outstanding contribution of peer reviewers to our evaluation process. As a token of our appreciation, eligible reviewers who have completed 3 or more reviews may designate one of their own research manuscripts for guaranteed external review when they submit to the corresponding journal.

Authors

Sarah Jackson

×

A new editor of the JCI
Rexford S. Ahima
Rexford S. Ahima
Published July 2, 2018
Citation Information: J Clin Invest. 2018;128(7):2653-2654. https://doi.org/10.1172/JCI122585.
View: Text | PDF

A new editor of the JCI

  • Text
  • PDF
Abstract

This issue of the Journal of Clinical Investigation marks the transition of the position of editor from Gordon Tomaselli to me. It is with great humility that I begin my tenure as the editor of the flagship journal of the American Society for Clinical Investigation (ASCI). On behalf of the JCI editorial board and editorial staff, I wish Gordon Tomaselli all the best in his new position as the dean of the Albert Einstein College of Medicine.

Authors

Rexford S. Ahima

×

Evolution of content — the Concise Communication
Gordon F. Tomaselli
Gordon F. Tomaselli
Published November 1, 2017
Citation Information: J Clin Invest. 2017;127(11):3915-3915. https://doi.org/10.1172/JCI97531.
View: Text | PDF

Evolution of content — the Concise Communication

  • Text
  • PDF
Abstract

Authors

Gordon F. Tomaselli

×

A change in editorship
Gordon F. Tomaselli
Gordon F. Tomaselli
Published June 30, 2017
Citation Information: J Clin Invest. 2017;127(7):2439-2440. https://doi.org/10.1172/JCI95387.
View: Text | PDF

A change in editorship

  • Text
  • PDF
Abstract

This edition of the Journal of Clinical Investigation marks the transition to a new editorial team from Johns Hopkins University. It is with great humility and excitement that we assume the mantle of the leading translational science journal in the world and the flagship of the American Society for Clinical Investigation.

Authors

Gordon F. Tomaselli

×

לְדוֹר וָדוֹר
Howard A. Rockman
Howard A. Rockman
Published June 1, 2017
Citation Information: J Clin Invest. 2017;127(6):2019-2020. https://doi.org/10.1172/JCI94813.
View: Text | PDF

לְדוֹר וָדוֹר

  • Text
  • PDF
Abstract

L’dor vador, transliterated from the Hebrew above, is an ancient concept in Judaic scripture meaning “from generation to generation,” which is now generally interpreted to mean that we have a responsibility to pass on teachings to future generations. It has been 5 years that I have been at the helm of the Duke-UNC Editorial Board of the Journal of Clinical Investigation and have had the privilege of publishing scientific knowledge that will be passed on to generations of future scientists. Now, with the selection of Dr. Gordon Tomaselli as the next editor in chief, I pass on the editorial duties for the JCI to him and his team at Johns Hopkins.

Authors

Howard A. Rockman

×

The postdoctoral apprenticeship
Ushma S. Neill
Ushma S. Neill
Published September 12, 2016
Citation Information: J Clin Invest. 2016. https://doi.org/10.1172/JCI90166.
View: Text | PDF

The postdoctoral apprenticeship

  • Text
  • PDF
Abstract

Much has been written already about whether the scientific machine is churning out too many PhDs and postdocs when there are a limited number of academic jobs and the competition for funding and space in competitive journals is intense. But gratifyingly, there exists a vast array of other scientific careers. We need to mentor and advise trainees about the diverse and rewarding professional opportunities that are available beyond the postdoctoral apprenticeship period.

Authors

Ushma S. Neill

×

New kid on the block
Howard A. Rockman
Howard A. Rockman
Published December 2, 2015
Citation Information: J Clin Invest. 2015. https://doi.org/10.1172/JCI85448.
View: Text | PDF

New kid on the block

  • Text
  • PDF
Abstract

As Editor of the Journal of Clinical Investigation, I am pleased to announce the January 2016 launch of JCI Insight, which will publish well-executed, high-quality research across biomedicine that presents a focused yet insightful line of investigation. The new journal, published under an open-access model, represents an expansion of the American Society for Clinical Investigation’s longstanding commitment to disseminating preclinical, translational, and early-phase clinical research that has the potential to advance the practice of medicine. JCI Insight will be the second Society publication since the JCI was founded in 1924.

Authors

Howard A. Rockman

×

The importance of being transparent
Sarah Jackson
Sarah Jackson
Published February 2, 2015
Citation Information: J Clin Invest. 2015;125(2):459-459. https://doi.org/10.1172/JCI80370.
View: Text | PDF

The importance of being transparent

  • Text
  • PDF
Abstract

In recent years, questions have been raised regarding the failure of some preclinical work to translate to clinical benefit and the inability to reproduce some high-profile studies. While myriad factors contribute to these problems, an important step in improving the integrity of published work is for journals to enforce rigorous reporting of methods and results.

Authors

Sarah Jackson

×

Happy Birthday JCI
Howard A. Rockman
Howard A. Rockman
Published October 1, 2014
Citation Information: J Clin Invest. 2014;124(10):4135-4136. https://doi.org/10.1172/JCI78708.
View: Text | PDF

Happy Birthday JCI

  • Text
  • PDF
Abstract

On the occasion of the ninetieth anniversary of the JCI, I am again humbled by the remarkable insight and passion of our pioneering founders when they created the Journal of Clinical Investigation in 1924.

Authors

Howard A. Rockman

×

Waste not, want not
Howard A. Rockman
Howard A. Rockman
Published February 3, 2014
Citation Information: J Clin Invest. 2014;124(2):463-463. https://doi.org/10.1172/JCI75011.
View: Text | PDF

Waste not, want not

  • Text
  • PDF
Abstract

As of the writing of this Editorial, the current JCI Editorial Board has evaluated approximately 7,000 manuscripts over the past 22 months for their suitability for publication in our journal. While many of you have received a negative decision on your manuscript, I suspect few are aware of the changes we have made to our review process to limit reviewers’ requests for what is in our view unnecessary and excessive experimentation.

Authors

Howard A. Rockman

×
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 23
  • 24
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts